KP
Kevin Puylaert sold $2K of SOPH stock
Kevin Puylaert, Chief Sales Officer of SOPHiA GENETICS SA (SOPH), sold 216 shares of SOPH stock worth $2K, per an SEC Form 4 filed Oct 7, 2026.
It was an open-market sale.
The trade happened on Oct 5, 2026, 2 days before it was made public.
SOPH has moved -24.0% since the trade date, from $8.20 to $6.23 (Nov 20, 2026 close).
- Traded
- Oct 5, 2026
- Disclosed
- Oct 7, 2026
- Filing delay
- 2 days
- Price since
- -24.0%
- Role
- Chief Sales Officer
- Source
- SEC Form 4